Emmaus Life Sciences, Inc.
Close on Oct 19, 2026
- Market cap
- $6.03M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 13, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 14, 2026 | During market hours | $6.30M | $0.02 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 15, 2026 | During market hours | $2.00M | $-0.05 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 31, 2026 | Before market open | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 14, 2025 | During market hours | $3.40M | $-0.03 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 14, 2025 | During market hours | $2.80M | $-0.02 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Apr 14, 2025 | During market hours | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 19, 2024 | During market hours | $5.50M | $0.03 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Jul 3, 2024 | Before market open | – | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Nov 14, 2023 | Before market open | – | – | – |
| Q2 FY2023 Ended Jun 30, 2023 | Aug 14, 2023 | During market hours | – | – | – |
| Q1 FY2023 Ended Mar 31, 2023 | May 15, 2023 | Before market open | – | – | – |
Press releases
Announcements Emmaus Life Sciences filed with the SEC
PRESS RELEASE DATED AUGUST 14, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED MAY 15, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED MARCH 30, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED DECEMBER 30, 2025
Material agreement · Other events · EX-99.1 to Form 8-K
NOVEMBER 14, 2025 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
AUGUST 14, 2025 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
MAY 15, 2025 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
APRIL 14, 2025 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
NOVEMBER 19, 2024 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
SEPTEMBER 10, 2024 PRESS RELEASE
Results of operations · Auditor change · EX-99.1 to Form 8-K
JULY 3, 2024 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
NOVEMBER 13, 2023 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
AUGUST 14, 2023 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
MAY 15, 2023 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
MARCH 31, 2023 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
NOVEMBER 14, 2022 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
AUGUST 15, 2022 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K
Emmaus Life Sciences Reports Q1
Results of operations · EX-99.1 to Form 8-K
MARCH 31, 2022 PRESS RELEASE
Results of operations · EX-99.1 to Form 8-K